首页> 外文期刊>Biomedical Research on Trace Elements >The Zinc Transporter SLC39A14/ZIP14 Controls G-protein Coupled Receptormediated Signaling Required for Systemic Growth.
【24h】

The Zinc Transporter SLC39A14/ZIP14 Controls G-protein Coupled Receptormediated Signaling Required for Systemic Growth.

机译:锌转运蛋白SLC39A14 / ZIP14控制系统生长所需的G蛋白偶联受体介导的信号传导。

获取原文
       

摘要

Zinc (Zn) confers structure and catalytic functions to a number of enzymes and transcription factors, and its homeostasis is tightly controlled by Zn transporters (SLC39/ZIP: importers, SLC30/ZnT: exporters). Zn is an essential trace element, and its deficiency is associated with abnormal endocrine-system reactions leading to vertebral growth retardation and metabolic disorders. However, the molecular mechanisms by which Zn affects the endocrine system remain to be clarified. Here we examined the in vivo roles of SLC39A14, a member of the SLC39 family, by generating its deficient mice. The Slc39a14 -knockout (KO) mice exhibit growth retardation accompanied by abnormal chondrocyte differentiation, reduced growth hormone production, and an impaired gluconeogenic program. We found that these phenotypes are attributable to impaired G-protein coupled receptor (GPCR)-mediated signaling, via the parathyroid hormone 1 receptor (PTH1R), growth hormone releasing hormone receptor (GHRHR), and glucagon receptor (GCGR), respectively, due to the degradation of cyclic adenosine monophosphate (cAMP) by the higher phosphodiesterase (PDE) activity in the Slc39a14 -KO mice. Thus, the Zn transporter SLC39A14 is a new regulator for GPCR-mediated signaling for systemic growth.
机译:锌赋予许多酶和转录因子结构和催化功能,其稳态由锌转运蛋白严格控制(SLC39 / ZIP:进口商,SLC30 / ZnT:出口商)。锌是必不可少的微量元素,其缺乏与内分泌系统异常反应有关,导致椎骨发育迟缓和代谢异常。但是,锌影响内分泌系统的分子机制仍有待阐明。在这里,我们通过产生SLC39A14缺陷小鼠,检查了SLC39A14(SLC39家族成员)的体内作用。 Slc39a14基因敲除(KO)小鼠表现出生长迟缓,伴有异常的软骨细胞分化,生长激素生成减少和糖原异生程序受损。我们发现这些表型分别归因于甲状旁腺激素1受体(PTH1R),生长激素释放激素受体(GHRHR)和胰高血糖素受体(GCGR)引起的受损的G蛋白偶联受体(GPCR)介导的信号传导。 Slc39a14 -KO小鼠中较高的磷酸二酯酶(PDE)活性导致环磷酸腺苷(cAMP)降解。因此,锌转运蛋白SLC39A14是GPCR介导的系统性生长信号的新调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号